Oct 13 (Reuters) - Medincell SA MEDCL.PA:
ANNOUNCED ON FRIDAY THAT FDA APPROVED EXPANDED INDICATION FOR UZEDY (RISPERIDONE) EXTENDED-RELEASE INJECTABLE SUSPENSION AS A TREATMENT FOR ADULTS LIVING WITH BIPOLAR I DISORDER
JOINT ANNOUNCEMENT WITH TEVA PHARMACEUTICALS TEVA.TA